Private equity (PE)-backed healthcare services organizations face a variety of complex challenges in today’s market. Many of these issues are beyond the control of financial sponsors, creating significant headwinds. Among the most pressing are increased regulatory scrutiny from state and federal authorities, particularly the Federal Trade Commission (FTC). In addition, the tightening of credit and liquidity in a high-interest-rate environment presents significant obstacles. The dynamics of supply and demand in healthcare further complicate the landscape. Demand for healthcare services is increasing due to an aging population, while the supply of healthcare providers is insufficient to meet these growing needs. This imbalance drives up the cost of hiring providers, further squeezing margins. Other key challenges include sunk costs from acquisitions made at high multiples, declining reimbursements from both private insurers and the Centers for Medicare & Medicaid Services (CMS), and heightened competition among PE firms for quality assets.
While these challenges are significant, there are areas where financial sponsors can exert influence. By focusing on operational improvements, talent retention, and strategic restructuring, PE firms can enhance the prospects of achieving a successful exit. This paper outlines key strategies financial sponsors can implement to overcome these headwinds and improve the performance of their healthcare services investments.
Key Market Challenges
Strategic Solutions for Overcoming Challenges
While external market conditions are difficult to control, PE firms can implement strategies to optimize operations, retain talent, and rationalize their portfolios. These efforts can improve the overall performance of healthcare services organizations and increase the likelihood of a successful exit.
Challenge: Physician burnout and a focus on work-life balance, particularly among younger clinicians, make retaining clinical talent a significant challenge. The cost of replacing experienced physicians with locum tenens is prohibitively high and can introduce quality risks.
Strategy: Retention of existing clinical staff should be a top priority for healthcare organizations. Key initiatives include:
Outcome: Reducing clinician turnover minimizes disruptions in patient care and lowers the costly reliance on locum tenens, enhancing both operational efficiency and profitability.
Challenge: Legacy compensation structures are often overly complex and create misaligned incentives that may lead to inefficiency and unnecessary administrative burdens.
Strategy: Simplifying and modernizing compensation models can drive productivity and streamline operations. Key steps include:
Outcome: Streamlined compensation models reduce administrative overhead, enhance clinician engagement, and improve financial alignment between clinical output and organizational objectives.
Challenge: Limited physician availability and uneven performance across practice locations can make it difficult to maintain an effective operational footprint.
Strategy: Rationalizing the portfolio by exiting underperforming locations can improve overall resource allocation and profitability. Steps to achieve this include:
Outcome: Streamlining the operational footprint allows for more efficient use of clinical resources and enhances the financial performance of remaining sites, improving the organization’s overall profitability and attractiveness to potential buyers.
Conclusion
Despite the many headwinds facing PE-backed healthcare services organizations, there are actionable strategies that financial sponsors can implement to improve their investment outcomes. By focusing on retaining clinical talent, simplifying compensation models, and rationalizing their operational footprint, PE firms can mitigate some of the external pressures and drive value creation. These efforts, while requiring significant investment in time and political capital, are essential to optimizing performance and increasing the likelihood of a successful exit.
In today’s challenging healthcare environment, it is more critical than ever for PE firms to take a proactive approach to addressing operational inefficiencies and enhancing clinical engagement. Those that do so will be better positioned to navigate the headwinds and capitalize on exit opportunities when they arise.
**********
William R. Leighton, Jr., M.D., M.B.A. is a practicing anesthesiologist and the founder and president of Clevehouse Advisors, LLC, a firm specializing in mergers and acquisitions, restructuring, and reorganization within the healthcare services sector. Prior to establishing Clevehouse, Dr. Leighton was a founding partner of US Anesthesia Partners.